Abstract
Purpose
This study aimed to identify the main indications for the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for bone repair and maintenance in the maxilla and mandible through a review of clinical trials evaluating the viability of using rhBMP-2 to delay the installation of dental implants, thus allowing satisfactory bone formation and long-term osseointegration.
Methods
Literature search of the PubMed/Medline databases was performed using the following MeSH index terms—“bone morphogenetic protein 2” and “dentistry”. Only clinical trials necessarily published in English, related to dentistry, and focused on bone reconstruction in critical defects, post-extraction alveoli, increasing the atrophic alveolar ridge, or surgery for maxillary sinus elevation were included, regardless of the age, sex, ethnicity, associated morbidities, or period of publication.
Results
Of the 17 studies identified based on the search filters, 2 were excluded. Therefore, 15 studies were finally included in this review.
Conclusions
Based on the results of our review, we concluded that the use of rhBMP-2 for the preservation of the alveolar ridge after tooth extraction or for increasing the local defects is safe and viable. The use of rhBMP-2/Bio-Oss® for the elevation of the maxillary sinus membrane is unnecessary; however, it can improve and accelerate the maturation process in cases of guided bone regeneration in peri-implant defects. Compounds comprising rhBMP-2, allogenic bone, and plasma-rich platelet (PRP) can act as autograft substitutes in mandibular critical defects.
Similar content being viewed by others
References
Urist MR (1965) Bone: formation by autoinduction. Science 150:893–899
Urist MR, Mikulski A, Lietze A (1979) Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 76:1828–1832
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW et al (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534
Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR et al (1989) Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 264:20805–20810
Wozney JM (2002) Overview of bone morphogenetic proteins. Spine (Phila Pa 1976) 27:S2–S8
Friess W, Uludag H, Foskett S, Biron R, Sargeant C (1999) Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm. Netherlands:91-99.
Uludag H, Gao T, Porter TJ, Friess W, Wozney JM (2001) Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am 83-A(Suppl 1):S128–S135
Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res:110-120.
Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev. Netherlands:1613-1629.
Marx RE, Armentano L, Olavarria A, Samaniego J (2013) rhBMP-2/ACS grafts versus autogenous cancellous marrow grafts in large vertical defects of the maxilla: an unsponsored randomized open-label clinical trial. Int J Oral Maxillofac Implants 28:e243–e251
Burkus JK, Gornet MF, Dickman CA, Zdeblick TA (2002) Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15:337–349
Marx RE, Harrell DB (2014) Translational research: The CD34+ cell is crucial for large-volume bone regeneration from the milieu of bone marrow progenitor cells in craniomandibular reconstruction. Int J Oral Maxillofac Implants 29(2):e201–e209
Kim YJ, Lee JY, Kim JE, Park JC, Shin SW, Cho KS (2014) Ridge preservation using demineralized bone matrix gel with recombinant human bone morphogenetic protein-2 after tooth extraction: a randomized controlled clinical trial. J Oral Maxillofac Surg 72(7):1281–1290
Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17(1):11–25
Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett RG (2005) De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63(12):1693–1707
Kao DW, Kubota A, Nevins M, Fiorellini JP (2012) The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation. Int J Periodontics Restorative Dent 32(1):61–67
Sharan A, Madjar D (2008) Maxillary sinus pneumatization following extractions: a radiographic study. Int J Oral Maxillofac Implants 23(1):48–56
LInd M, Eriksen EF, Bünger C (1996) Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 18(1):53–57
Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, Boyne PJ (2009) Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 67(9):1947–1960
Gamal AY, Aziz M, Salama MH, Iacono VJ (2014) Gingival crevicular fluid bone morphogenetic protein-2 release profile following the use of modified perforated membrane barriers in localized intrabony defects: a randomized clinical trial. J Int Acad Periodontol 16(2):55–63
Alonso N, Risso GH, Denadai R, Raposo-Amaral CE (2014) Effect of maxillary alveolar reconstruction on nasal symmetry of cleft lip and palate patients: a study comparing iliac crest bone graft and recombinant human bone morphogenetic protein-2. J Plast Reconstr Aesthet Surg 67(9):1201–1208
Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17(2):124–139
Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H (2000) Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 71(8):1241–1257
Bianchi J, Fiorellini JP, Howell TH, Sekler J, Curtin H, Nevins ML, Friedland B (2004) Measuring the efficacy of rhBMP-2 to regenerate bone: a radiographic study using a commercially available software program. Int J Periodontics Restorative Dent 24(6):579–587
Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M (2005) Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 76(4):605–613
de Freitas RM, Susin C, Spin-Neto R, Marcantonio C, Wikesjö UM, Pereira LA, Marcantonio E Jr (2013) Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial. J Clin Periodontol.
Coomes AM, Mealey BL, Huynh-Ba G, Barboza-Arguello C, Moore WS, Cochran DL (2014) Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone. J Periodontol 85(4):525–535
Jung RE, Glauser R, Schärer P, Hämmerle CH, Sailer HF, Weber FE (2003) Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14(5):556–568
Jung RE, Windisch SI, Eggenschwiler AM, Thoma DS, Weber FE, Hämmerle CH (2009) A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2. Clin Oral Implants Res 20(7):660–666
Jensen ED, Pham L, Billington CJ Jr, Espe K, Carlson AE, Westendorf JJ, Petryk A, Gopalakrishnan R, Mansky K (2010) Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. J Cell Biochem 109(4):672–682. doi:10.1002/jcb.22462
Hayden RE, Mullin DP, Patel AK (2012) Reconstruction of the segmental mandibular defect: current state of the art. Curr Opin Otolaryngol Head Neck Surg 20(4):231–236
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gomes-Ferreira, P.H.S., Okamoto, R., Ferreira, S. et al. Scientific evidence on the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in oral and maxillofacial surgery. Oral Maxillofac Surg 20, 223–232 (2016). https://doi.org/10.1007/s10006-016-0563-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-016-0563-4